Navigation Links
Lecture to honor victim of Sept. 11 tragedy
Date:9/11/2007

Boston, MA--Boston University School of Medicine (BUSM) will present The Sixth Annual Sue Kim Hanson Lecture in Immunology on Friday, September 14, 2007 at noon. The annual lecture is in honor of Sue Kim Hanson, MA, PhD 02, a former researcher in BUSMs Pulmonary Center. Kim Hanson, along with her husband and daughter, were passengers on United Airline flight 175, the second plane that struck the World Trade Center on September 11, 2001.

The lecture titled, Mechanisms of Signal Integration in Innate Immunity, will focus on how innate immune cells respond to viral infections by directing the synthesis of anti-viral proteins. It will be presented by Tom Maniatis, PhD, the Thomas H. Lee professor of molecular and cellular biology at Harvard University.

Maniatis has been an international leader in the fields of molecular and cellular biology where his studies have provided critical insights regarding mechanisms of RNA transcription, pre-mRNA splicing and signal transduction. In 1982 he co-authored Molecular Cloning-A Laboratory Manual, a text that revolutionized the way modern biological research is conducted in the laboratory. His current research explores the regulation of innate immunity and the role of gene expression in brain development and function.

Kim Hanson moved to Boston and earned a MA degree in medical sciences from BUSM in 1992. After graduation, she joined the Schools Pulmonary Center. She then concurrently entered the PhD program in the department of pathology and laboratory medicine at BUSM.

Her thesis project was an investigation of the role of interleukin-16 in immunity and targeted deletion of the interleukin-16 gene in mice. Her degree was awarded posthumously by unanimous vote by the thesis committee.

Sue was on her way to a promising career in molecular biology, said David Center, MD, Gordon and Ruth Snider Professor of Pulmonary Medicine, Professor of Medicine and Biochemistry at BUSM
'/>"/>

Contact: Gina DiGravio
gina.digravio@bmc.org
617-638-8491
Boston University
Source:Eurekalert

0

GOOD

Page: 1 2

Related biology news :

1. APS lecturer shows rare video of teacher-student immune cell interactions in live animal
2. Old dinosaur research leads to new honor
3. New tooth enamel dating technique could help identify disaster victims
4. Spray-on skin relieves emotional trauma for child burn victims
5. Malaria vaccine prompts victims immune system to eliminate parasite from mosquitoes
6. Traumas like Sept. 11 make brains more reactive to fear
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/7/2009)...uary 7 WCC Smart Search & Matc...h and match software, today,announced that Tarvin...t of,Sales for the ID market. , Mr. Sembhi...anagement,industry. He was most recently Presiden...ble for strategic product development, corporate b...
(Date:1/7/2009)...hoosing repeat cesarean deliveries and having them...are up to two times more likely to have a baby wit...ress resulting in mechanical ventilation and NICU ...ta, M.D., Ph.D., assistant professor in the UAB De...Maternal-Fetal Medicine, and colleagues reported i...
(Date:1/7/2009)...pollution has already spurred public health offici...e a more pressing concern in a warmer world. , S...of the journal Oecologia . , Sue Natali, a post...Florida and the paper,s lead author, compared merc...iched with carbon dioxide to soil beneath trees in...
(Date:1/7/2009)...omatase, the key enzyme required for the body to m...e structural biology work done by the Ghosh lab at...(HWI) in Buffalo, New York. Dr. Debashis Ghosh,s ...matase is the first time that scientists have been...strogen. , In fact, the Ghosh lab has determine...
Breaking Biology News(10 mins):Repeat C-section before 39 weeks raises risk of neonatal illness 2To climate-change worries, add 1 more: Extended mercury threat 2To climate-change worries, add 1 more: Extended mercury threat 3HWI scientist first in world to unravel structure of key breast cancer target enzyme 2HWI scientist first in world to unravel structure of key breast cancer target enzyme 3Taxotere 28R 29 Based Chemotherapy Significantly Improved Overall Survival Compared With Standard Anthracycline Based Chemotherapy in Early Stage Brea 2189 1Taxotere 28R 29 Based Chemotherapy Significantly Improved Overall Survival Compared With Standard Anthracycline Based Chemotherapy in Early Stage Brea 2189 2Taxotere 28R 29 Based Chemotherapy Significantly Improved Overall Survival Compared With Standard Anthracycline Based Chemotherapy in Early Stage Brea 2189 3Taxotere 28R 29 Based Chemotherapy Significantly Improved Overall Survival Compared With Standard Anthracycline Based Chemotherapy in Early Stage Brea 2189 4Taxotere 28R 29 Based Chemotherapy Significantly Improved Overall Survival Compared With Standard Anthracycline Based Chemotherapy in Early Stage Brea 2189 5High Dose Chemo Provides Little Benefit to Breast Cancer Patients 8210 1High Dose Chemo Provides Little Benefit to Breast Cancer Patients 8210 2High Dose Chemo Provides Little Benefit to Breast Cancer Patients 8210 3Top physics laboratories sign up to open access with PhysMath Central 1586 1Top physics laboratories sign up to open access with PhysMath Central 1586 2New technique reveals insights into lung disease 8206 1New technique reveals insights into lung disease 8206 2
...ld seeps--strange clams, mussels and sea snails th...nts--are on average older than the marine mollusk ... the 8 September issue of the journal Science, pub...n average, the first appearance of cold seep mollu... earlier than that of marine mollusks in general, ...
...blems often relies on the direct, linear relations...encoding that protein. In fact, colinearity of DNA...tal feature of the universal genetic code. However...m the Brussels Branch of the global Ludwig Institu...d Fred Hutchinson Cancer Research Center (FHCRC), ...
...lague and some forms of food poisoning "paralyze" ...way, according to a new study in the September 8, ...Press. , The researchers found that these bacteria...tein that mimics an apparently unrelated mammalian...apacity to change shape and move, abilities import...
...e database of seashells 15 years ago, Dr. Gary Ros...-keeping would eventually shed light on a 40-year-...e mechanism underlying the island rule: that small...han their mainland relatives, and large animals ev...September in the Journal of Biogeography, "The Isl...
Other Biology News:Ocean seep mollusks may share evolutionary history with other deep-sea creatures 2Ocean seep mollusks may share evolutionary history with other deep-sea creatures 3Protein splicing upsets the DNA colinearity paradigm 2Study illuminates how the plague bacteria causes disease 2Study illuminates how the plague bacteria causes disease 3Scientist's persistence sheds light on marine science riddle 2
(Date:1/7/2009)...uary 7, 2008 Researchers from Harvard University ...easured, for the first time, a repulsive quantum m...ed for a wide range of new nanotechnology applicat...rt L. Wallace Professor of Applied Physics at Harv...EAS), will be published as the January 8 cover sto...
(Date:1/7/2009)...if., Jan. 7 Nuvelo, Inc....holders of Nuvelo have approved,the issuance of N...t dated,September 24, 2008, as amended, between N...velo,s stockholders also voted to adjourn Nuvelo,s...09, to solicit additional proxies in,favor of a p...
(Date:1/7/2009)...f., Jan. 7 Amgen (Nasdaq...an Global Healthcare Conference at 9:00 a.m. Pacif.... Francis in San Francisco, Calif. Amgen Chairman...ce. Live audio of the presentation will be availab...n,s Web site, www.amgen.com , under Investors. ,...
(Date:1/7/2009)... 7 Volcano Corporation,...nufacturing and sales of,products for the diagnos...,disease, said today that it has closed its previ..., Inc. , Axsun is a leading developer and m... medical Optical Coherence Tomography (OCT) imagin...
Breaking Biology Technology:Researchers measure elusive repulsive force from quantum fluctuations 2Nuvelo Shareholders Approve Issuance of Common Stock Pursuant to Merger Agreement With ARCA biopharma 2Nuvelo Shareholders Approve Issuance of Common Stock Pursuant to Merger Agreement With ARCA biopharma 3Nuvelo Shareholders Approve Issuance of Common Stock Pursuant to Merger Agreement With ARCA biopharma 4Nuvelo Shareholders Approve Issuance of Common Stock Pursuant to Merger Agreement With ARCA biopharma 5Volcano Announces Closing of Axsun Technologies Acquisition 2
..., Wis. - The Medical College of Wisconsin has an...r of cell biology, has received a grant from the ...idney Diseases . , ,The five-year, $1.8 million gr... his team in their work to identify protein factor...esearch into these factors may contribute to futur...
..., Wis. - A new automated anti-money laundering ap...cious financial transactions is helping banks comp...rity. , ,In a move to support clients working to c... The USA Patriot Act and the Bank Secrecy Act (B...ncial technology subsidiary of Marshall & Ilsley ...
...Wis. - The complex goal of integrating patient me...ultiple sites of care is moving closer to reality ...ymphony Corp. , headquartered in Madison, and the ...a novel clinical information-sharing model in the ...d" model utilizes a peer-to-peer record locator se...
...Wis. - A Madison-based company experienced in pro...e $150,000 from Congress to help finance a biotech...ubator was included at the request of U.S. Rep. T...l passed Wednesday in the House of Representatives...d the final version must be signed by President Bu...
Other Biology Technology:Metavante application aimed at compliance 2Symphony Corp. and CareEvolution to partner 2Baldwin backs funding for Midwest biotech incubator 2
Ezrin/Radixin/Moesin Antibody
Rabbit polyclonal to Taura Syndrome Virus Coat Protein ( Abpromise for all tested applications). Antigen: Synthetic peptide: VTNSEGSTIL MNDIPITNQN VVLSKNVTDN LFEVQDQALI ESLSRDVLLH NDSWTSSDDE IGT
JAB1 Immunogen: Synthetic peptide, conjugated to KLH, corresponding to residues S(201) E Y Q T I P L N K I E D F G V(216) of human JAB1. The sequence is identical in mouse and rat. Storage: -
Anti-Mouse Ly 6C.2 , Ascites (Clone 5075-3.6) (mouse IgG2b)
Biology Products: